Intrinsic Value of S&P & Nasdaq Contact Us

Milestone Scientific Inc. MLSS NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
56/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+1269.9%

Milestone Scientific Inc. (MLSS) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

The consensus price target is $4.00, representing an upside of 1269.9% from the current price $0.29.

Analysts estimate Earnings Per Share (EPS) of $-0.05 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.06 vs est $-0.05 (missed -20%). 2025: actual $-0.07 vs est $-0.07 (beat +0%). Analyst accuracy: 92%.

MLSS Stock — 12-Month Price Forecast

$4.00
▲ +1,269.86% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for Milestone Scientific Inc., the price target is $4.00.
The average price target represents a +1,269.86% change from the last price of $0.29.

MLSS Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Milestone Scientific Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — MLSS

92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.06 vs Est –$0.05 ▼ 16.7% off
2025 Actual –$0.07 vs Est –$0.07 ▼ 0.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — MLSS

95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.009B vs Est $0.009B ▼ 7.8% off
2025 Actual $0.009B vs Est $0.009B ▼ 2.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message